Technology area: Chemistry & Materials
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Largan Medical Co. Ltd. manages 4 pending office actions in the Chemistry & Materials technology area. These actions are distributed among 4 distinct examiners and 3 distinct art units, indicating a mix of technical focuses. The use of 3 distinct art units suggests that the company's chemical or material research is being evaluated by several different specialized groups within the patent office. This distribution means the company must navigate the requirements of 3 distinct art units, each with its own set of examination standards and timelines.
LEE, DORIS L is the busiest examiner for the portfolio, currently managing 1 pending office action. With 4 pending office actions in total and 4 distinct examiners involved, the workload is spread such that each examiner is responsible for exactly one matter. This lack of examiner concentration means that prosecution strategies must be tailored to the specific tendencies of four different individuals. The presence of 4 distinct examiners across 3 distinct art units highlights the need for a versatile approach to the company's Chemistry & Materials portfolio.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, DORIS L | 1 | 58.7% | +8.8% |
| BROWN, MADISON ELIZABETH | 1 | — | — |
| EGWIM, KELECHI CHIDI | 1 | 69.7% | +14.7% |
| GRANNUM, VERITA EUDORA EBUN | 1 | 61.3% | +45.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18210941 | PLASTICIZER, PLASTIC COMPOSITION, AND PLASTIC PRODUCT | EGWIM, KELECHI CHIDI | 28d |
| 18394541 | PLASTICIZER, PLASTIC COMPOSITION, AND PLASTIC PRODUCT | LEE, DORIS L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18210941 | PLASTICIZER, PLASTIC COMPOSITION, AND PLASTIC PRODUCT | EGWIM, KELECHI CHIDI | 28d |
| 18155832 | POLYMER, ELECTROLYTE AND BATTERY | GRANNUM, VERITA EUDORA EBUN | 29d |
| Art Unit | Apps |
|---|---|
| 1787 | 1 |
| 1762 | 1 |
| 1721 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18394541 | PLASTICIZER, PLASTIC COMPOSITION, AND PLASTIC PRODUCT | LEE, DORIS L | — | §102§103 | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18530328 | COMPOSITION, ANODE AND BATTERY | BROWN, MADISON ELIZABETH | 1787 | §103 | Non-Final OA | — | Pending | Dec 06, 2023 |
| 18210941 | PLASTICIZER, PLASTIC COMPOSITION, AND PLASTIC PRODUCT | EGWIM, KELECHI CHIDI | 1762 | §102§103 | Non-Final OA | 28d | Pending | Jun 16, 2023 |
| 18155832 | POLYMER, ELECTROLYTE AND BATTERY | GRANNUM, VERITA EUDORA EBUN | 1721 | §103 | Non-Final OA | 29d | Pending | Jan 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLargan Medical Co. Ltd. has 4 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Doris L Lee has the most, with 1 of Largan Medical Co. Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
